Desferrioxamine (DF) effectively manages iron overload in transfusion-dependent thalassemia major patients. Subcutaneous DF administration helps achieve iron balance with no significant adverse effects observed.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: